TBPH Theravance Biopharma
- 8.290
- -0.120-1.43%
- 8.140
- -0.150-1.81%
Theravance Biopharma News
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sawaf Aziz
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Miller Aine
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Grimaud Brett A.
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Farnum Rhonda
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director PAKIANATHAN DEEPIKA
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director O'Connor Donal
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director MITCHELL DEAN J
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director GRAY SUSANNAH
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Grant Jeremy T
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Smaldone Alsup Laurie
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BROSHY ERAN
Theravance Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Madison Avenue International LP(17.5%),Madison Avenue Partners, LP(17.5%), etc.
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner Samaha Eli
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Winningham Rick E
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sawaf Aziz
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Miller Aine
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Grimaud Brett A.
Theravance Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Farnum Rhonda
Analysis
Price Target
No Data
